Abstract
WNT/β-catenin signaling is critical to the development of many cancer types. A paper by Mo and colleagues in a recent issue of Cell shows that autocrine CXCL12/CXCR4 chemokine signaling activates β-catenin signaling in a rare peripheral nerve sarcoma. Together with the availability of small molecules targeting CXCR4, this finding suggests new avenues for cancer therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 269-271 |
| Number of pages | 3 |
| Journal | Cancer Cell |
| Volume | 23 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 18 2013 |